Find Therapeutics secured CA$10 million in funding to continue advancing tasronetide, its treatment to restore damaged myelin ...
Evogene and Unravel Biosciences are collaborating to use AI to speed the development of therapies that promote myelin sheath ...
The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, today announced the publication of a study in ...
The disruption of axons—the thread-like part of nerve cells that transmits electrical signals—is associated with Alzheimer’s disease. One way axonal function may be hindered is through damage to the ...
MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback